Program Directors

Irl B. Hirsch, MD; University of Washington 
Linda Siminerio, PhD; University of Pittsburgh Diabetes Institute

Presenters

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Timothy S Bailey, MD: Consultant, Bayer, BD, Calibra, Lilly, Medtronic, Novo Nordisk, sanofi; Researcher, Versartis, Yofimeter; Speaker, Insulet, Medtronic, Novo Nordisk, sanofi

Bruce A. Buckingham, MD: Advisory Board Member, Animas, Halozyme, Novo Nordisk, Sanofi; Advisory Board Member and Investigator, Convatec, Medtronic, Tandem; Investigator, Bayer, Dexcom

Mark A. Clements, MD: Advisory Group Member, Glooko/Diasend

Robert H. Eckel, MD: Consultant, Merck & Co. Novo Nordisk, Consultant; Sanofi; Independent Contractor, UniQure; Researcher, Ionis

Alison B. Evert, MS: Medical Advisory Board Member, Seseonice

Carla J. Greenbaum, MD: Consultant, Bristol-Myers Squibb, Pfizer, Inc.; Principal Investigator, Jansen Pharmaceuticals, Novo Nordisk

Irl B. Hirsch, MD: Consultant, Abbott laboratories, Roche Diagnostics, Intarcia, Valeritas

Janet B. McGill, MD: Advisory Group Member, Jansen Pharmaceuticals, Merck & Co.; Committee Member, Boehringer-Ingelheim; Speaker, Jansen Pharmaceuticals

William H. Polonsky, PhD: Consultant, Abbott Laboratories, Astra Zeneca, Dexcom, Eli Lilli & Company, Novo Nordisk, Roche Diagnostics

Guillermo E. Umpierrez, MD: Consultant, Ad Hoc, Sanofi; Principal Investigator, Astra Zeneca, Merck & Co., Sanofi

The faculty reported the no relevant financial relationship: Roy W Beck, MD; Luisa A Duran, MD; Margaret S. Eckel; Peter J. Eckel; James S. Hirsch; Michael Riddell, MD; Desmond A Schatz, MD; Sandra Sobel, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.